Raising Cane's opening new locations in 6 states in August. Here's where.
After opening five new restaurants in July, the Baton Rouge, Louisiana-based chain known for its chicken fingers said in a statement to USA TODAY it is opening seven more locations across six states in August, including its first restaurant in the Long Beach, California area.
Other states getting new locations include Florida, Wisconsin and Maryland, among others, Raising Cane's said in an emailed statement on July 28.
Here's what to know about this month's Raising Cane's openings.
Which states are getting new Raising Cane's locations?
New restaurants are scheduled to open at the following locations on the following dates, according to the chain:
Aug. 5: 323 William S Canning Blvd., Fall River, Massachusetts
Aug. 5: 2742 Tyrone Blvd N., St. Petersburg, Florida
Aug. 7: 1850 Oakland Ave., Indiana, Pennsylvania
Aug. 12: 1741 Claribel Rd., Riverbank, California
Aug. 19: 6803 Ritchie Hwy., Glen Burnie, Maryland
Aug. 19: 3740 WI-16, La Crosse, Wisconsin
Aug. 26: 119 E. Carson St., Long Beach, California
What is Raising Cane's?
The company sells chicken sandwiches and chicken finger combos including crinkle-cut fries, Texas Toast, coleslaw and Cane's sauce, which the company says is made with a "special blend of spices."
Raising Cane's owner Todd Graves initially planned to call his restaurant Sockeye's, a nod to the salmon he once fished in Alaska.
However, a friend suggested he name the company after his yellow Labrador Retriever, Raising Cane, who spent lots of time at the construction site of the first Raising Cane's location at the north gates of Louisiana State University.
The dog, Cane I, served as the company's mascot until he died in 1998, according to the chain. He was friendly and loved to wear Graves' sunglasses.
Raising Cane's second mascot, Cane II, stepped into her role in 1999. She was a therapy dog who visited hospital patients around the country. As the company mascot, Cane II spent time at the company's Restaurant Support Office and attended community events until 2016.
Most recently, Cane III, born in 2017, was appointed mascot.
"She loves visiting Raising Cane's Restaurants and receiving belly rubs from crewmembers," the company said, noting that Raising Cane's fans can follow her on social media at @RaisingCane3.
Saleen Martin is a reporter on USA TODAY's NOW team. She is from Norfolk, Virginia – the 757. Email her at sdmartin@usatoday.com.
Gabe Hauari is a national trending news reporter at USA TODAY. You can follow him on X @GabeHauari or email him at Gdhauari@gannett.com.
This article originally appeared on USA TODAY: Raising Cane's opening new restaurant locations in 6 states in August
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Atombeat and BioDuro link for peptide drug discovery platform
Atombeat and BioDuro have announced a strategic partnership to launch an AI-powered platform aimed at accelerating peptide drug discovery. The collaboration combines Atombeat's expertise in in silico modelling with BioDuro's capabilities in discovery chemistry, biology, and drug metabolism and pharmacokinetics. The initiative is set to enhance the development of next-generation peptides, quality candidates with quick timelines and cost-effectiveness across various therapeutic areas. Atombeat expedites the discovery of drugs using its Hermite software and RiDYMO platform, incorporating technologies such as Uni-Dock and Reinforced Dynamics. These tools enable the exploration of a digital library with over one trillion potential peptide compounds, streamlining the early drug discovery process. By focusing on the most promising candidates, the platform is designed to save cost, time and effort in drug development. BioDuro's role in the partnership is to leverage its synthesis capability for producing several peptide compounds in parallel. The company will be able to deliver pure peptides within one week, without the need for purification steps. This integrated approach aims to significantly reduce research and development timelines and associated costs and risks. BioDuro CEO Dr Armin Spura stated: 'We are excited to advance peptide innovation through our strategic partnership with Atombeat. Atombeat brings extensive experience in AI-assisted drug design and optimisation. 'Together, we aim to provide the industry with leading services in peptide drug development, accelerating smarter and more efficient peptide research, and delivering faster and comprehensive solutions to our global clients.' The AI-accelerated platform will facilitate a seamless workflow from molecular design to preclinical candidate selection. It is expected to deliver cyclic peptides that meet key developability traits, such as membrane permeability, across a broad range of therapeutic areas. "Atombeat and BioDuro link for peptide drug discovery platform" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
4 minutes ago
- Yahoo
Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call
Company will host conference call at 4:30 p.m. ET, on Tuesday, August 12, 2025 CELEBRATION, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the second quarter 2025 on Tuesday, August 12, 2025, via a news release after the market close, and will host a conference call/audio webcast at 4:30 p.m. ET that day. A link to the audio webcast will be accessible on the 'Events & Presentations' page in the Investor Relations section of Zevra's website at To join via telephone, please use the following dial-in information: (800) 245-3047 (United States) +1 (203) 518-9765 (International) Conference ID: ZVRAQ225 A replay of the webcast will be available for 90 days beginning at approximately 5:30 p.m. ET. The replay will be accessible on the 'Events & Presentations' page of Zevra's website at About Zevra Therapeutics, Inc. Zevra Therapeutics, Inc. is a commercial-stage company combining science, data, and patient needs to create transformational therapies for rare diseases with limited or no treatment options. Our mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, the Company is overcoming complex drug development challenges to make new therapies available to the rare disease community. For more information, please visit or follow us on X and LinkedIn. Caution Concerning Forward-Looking Statements This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding upcoming events or Zevra's participation at such events. Forward-looking statements are based on information currently available to Zevra and its current plans or expectations. They are subject to several known and unknown uncertainties, risks, and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. These and other important factors are described in detail in the "Risk Factors" section of Zevra's Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 12, 2025, and Zevra's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed on May 13, 2025, and Zevra's other filings with the SEC. While we may elect to update such forward-looking statements at some point in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. Although we believe the expectations reflected in such forward-looking statements are reasonable, we cannot assure that such expectations will prove correct. These forward-looking statements should not be relied upon as representing our views as of any date after the date of this press release. Zevra Contact Nichol Ochsner +1 (732) 754-2545 nochsner@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Stealth Startups CEO Guy Costantini Shares Belief-Driven Leadership Model on DesignRush Podcast
In Episode No. 100 of the DesignRush Podcast, Guy Costantini breaks down how caring more than shouting, hiring believers, and building with community-first strategies drive lasting startup success in stealth mode. Miami, Florida--(Newsfile Corp. - August 4, 2025) - Guy Costantini, CEO of Stealth Startups Careers and former global marketing exec behind gaming hits like League of Legends and The Witcher, joined Episode No. 99 of the DesignRush Podcast to share how stealth-mode founders can scale with community-first strategies, ethical monetization, and humble leadership. Source: DesignRush To view an enhanced version of this graphic, please visit: In the episode, Costantini outlines why the most resilient startups don't rely on hype-they're built on trust, belief, and adaptability. "I have to really care about the thing that you are trying to bring to market," Costantini shares. "Vision and conviction are required… but adaptability is the human trait that has made us successful." Tune in to learn: Why belief-based hiring powers stealth startup momentum How global fan communities fuel traction faster than ads Why "win-win" monetization loops build brand nostalgia, not burnout How AI fits into creative leadership (hint: utility > hype) Why adaptability is the 2025 founder edge Costantini, who has led launches for some of gaming's most loved franchises, emphasizes that community is the strategic foundation. "Focus on where the magic of the fun for players is and kind of pull at that frame and build upon that." On monetization, he warns against extractive models: "You can strip mine the hell out of a category and maybe you'll get really rich... but it's destructive to our industry." Instead, his startup model focuses on lean, self-funded teams, where every hire is mission-aligned and globally distributed. "The only people working with us are people who really believe." From launching stealth ventures to steering creative teams through ambiguity, Costantini's leadership framework offers actionable insights for tech leaders, indie founders, and creative entrepreneurs navigating the modern startup landscape. Want to be featured on the DesignRush Podcast? Send an email to spotlight@ About Guy Costantini Guy Costantini is the co-founder and CEO of Stealth Startups Careers. With 16 years of experience across games, community-building, and global brand strategy, his work has helped shape major titles like League of Legends, Marvel Contest of Champions, and The Witcher. He is a vocal advocate for belief-led hiring, ethical monetization, and adaptability in leadership. About DesignRushDesignRush is a media platform and a B2B marketplace connecting businesses with agencies through expert reviews and agency ranking lists, awards, knowledge resources, and personalized agency recommendations for vetted projects. Media ContactMonika KalinovaHead of PR+1 305-370-1017monika.k@ To view the source version of this press release, please visit Sign in to access your portfolio
